We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

INEO:NASDAQINNEOVA Holdings Limited Analysis

Data as of 2026-05-19 - not real-time

$0.60

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The stock is trading just above its 20‑day SMA and slightly below the 50‑day SMA, with the RSI hovering around the neutral 50 mark, suggesting no strong momentum bias. Technical signals are mixed: the MACD histogram is negative and the MACD line sits below the signal line, indicating bearish pressure, while volume has been on a decreasing trend, raising concerns about liquidity. The price is approaching a identified support level near $0.49, and the 30‑day volatility exceeds 100%, reflecting a highly erratic price path, though the beta of roughly 0.77 points to lower systematic risk relative to the market.
Fundamentally, the company posted a steep revenue decline of over 20% and operates with negative gross and operating margins, a modest cash balance versus a sizable debt load, and a negative return on equity. Despite these challenges, a discounted cash‑flow model values the business at nearly $4 per share, far above the current market price of about $0.60, and the market sentiment index reads “Extreme Greed,” implying speculative interest despite the weak financial profile. The firm pays no dividend, and its exposure to multiple regions—including Singapore and the Middle East—adds geographic and currency considerations to the risk mix.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Bearish MACD alignment
  • Decreasing volume and approaching support
  • Neutral RSI and high short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Significant gap between market price and DCF fair value
  • Potential for turnaround if cost structure improves
  • Current market sentiment indicating speculative upside

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Sustained negative margins and high debt burden
  • Exposure to cyclical auto‑parts demand
  • Absence of dividend and uncertain earnings outlook

Key Metrics & Analysis

Financial Health

Revenue Growth-20.60%
Profit Margin-0.68%
ROE-5.73%
ROA-0.08%
Debt/Equity398.57
P/B Ratio0.9
Op. Cash Flow$4.4M
Free Cash Flow$6.2M

Technical Analysis

TrendNeutral
RSI51.4
Support$0.49
Resistance$0.83
MA 20$0.63
MA 50$0.56
MA 200$0.70
MACDBearish
VolumeDecreasing
Fear & Greed Index89.18

Valuation

Fair Value$3.96
GradeUndervalued
TypeValue

Risk Assessment

Beta0.77
Volatility105.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.